A New Paradigm to Mitigate Osteosarcoma by Regulation of MicroRNAs and Suppression of the NF-κB Signaling Cascade
Open Access
- 1 December 2014
- journal article
- Published by Korean Society of Developmental Biology in Development and Reproduction
- Vol. 18 (4) , 197-212
Abstract
Osteosarcoma (OS) is one of the most common malignant primary bone tumors and NF-κB appears to play a causative role, but the mechanisms are poorly understood. OS is one of the pleomorphic, highly metastasized and invasive neoplasm which is capable to generate osteoid, osteoclast and osteoblast matrix. Its high incidence has been reported in adolescent and children. Cell signal cascade is the pivotal functional mechanism acquired during the differentiation, proliferation, growth and survival of the cells in neoplasm including OS. The major limitation to the success of chemotherapy in OS is the development of multidrug resistance (MDR). Answers to all such queries might come from the knock-in experiments in which the combined approach of miRNAs with NF-κB pathway is put into use. Abnormal miRNAs can modulate several epigenetical switching as a hallmark of number of diseases via different cell signaling. Studies on miRNAs have opened up the new avenues for both the diagnosis and treatment of cancers including OS. Collectively, through the present study an attempt has been made to establish a new systematic approach for the investigation of microRNAs, biophysiological factors and their target pairs with NF-κB to ameliorate oncogenesis with the "bridge between miRNAs and NF-κB". The application of NF-κB inhibitors in combination with miRNAs is expected to result in a more efficient killing of the cancer stem cells and a slower or less likely recurrence of cancer.Keywords
Funding Information
- National Research Foundation of Korea (2014-1128)
This publication has 79 references indexed in Scilit:
- miR‐16 inhibits cell proliferation by targeting IGF1R and the Raf1–MEK1/2–ERK1/2 pathway in osteosarcomaFEBS Letters, 2013
- Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cellsJournal of Cell Science, 2012
- MicroRNA-199a-3p Is Downregulated in Human Osteosarcoma and Regulates Cell Proliferation and MigrationMolecular Cancer Therapeutics, 2011
- The Molecular Pathogenesis of Osteosarcoma: A ReviewSarcoma, 2011
- NF-κB, Inflammation, and Metabolic DiseaseCell Metabolism, 2011
- Viral Infection and Cancer: The NF-κB/Snail/RKIP Loop Regulates Target Cell Sensitivity to Apoptosis by Cytotoxic LymphocytesCritical Reviews in Immunology, 2010
- Regulation of MicroRNA Biogenesis: A miRiad of mechanismsCell Communication and Signaling, 2009
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseasesCell Research, 2008
- Is NF-κB a culprit in type 2 diabetes?Biochemical and Biophysical Research Communications, 2005
- The Crohn's Disease Protein, NOD2, Requires RIP2 in Order to Induce Ubiquitinylation of a Novel Site on NEMOCurrent Biology, 2004